Related Experiment Video
Updated: Mar 6, 2026
12:26
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
19.4K
Cdk5: An Emerging Kinase in Pain Signaling.
Tej Kumar Pareek1, Lisa Zipp1, John J Letterio1
1Department of Pediatrics, Division of Pediatric Hematology and Oncology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Brain Disorders & Therapy
|March 21, 2017
Summary
Chronic pain involves altered pain signaling pathways. Research highlights the therapeutic potential of targeting Cyclin-dependent kinase 5 (Cdk5) for developing new pain relievers.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Pain is a crucial survival mechanism, but chronic pain involves altered pain signaling pathways, leading to conditions like allodynia and hyperalgesia.
- Protein kinases play vital roles in cellular homeostasis and disease pathogenesis, with recent focus on their involvement in neuronal plasticity and pain sensitization.
- The pharmaceutical industry is actively exploring kinase inhibitors as potential analgesics due to their specificity and selectivity.
Purpose of the Study:
- To review recent advancements in understanding the role of Cyclin-dependent kinase 5 (Cdk5) in pain signaling.
- To discuss the therapeutic potential of Cdk5 as a target for novel pain management strategies.
Main Methods:
- Literature review of recent research on Cdk5 in pain biology.
- Analysis of molecular and cellular mechanisms underlying Cdk5's role in pain sensitization.
- Exploration of Cdk5's potential as a therapeutic target for chronic pain.
Main Results:
- Cdk5 has emerged as a significant kinase involved in regulating neuronal plasticity and pain sensitization.
- Specific and selective Cdk5 inhibitors show promise for developing effective analgesics.
- Understanding Cdk5's pathways is key to developing targeted pain therapies.
Conclusions:
- Cyclin-dependent kinase 5 (Cdk5) is a critical player in pain signaling pathways.
- Targeting Cdk5 presents a promising therapeutic avenue for managing chronic pain conditions.
- Further research into Cdk5 inhibitors could lead to the development of novel analgesic drugs.
Related Concept Videos
01:07MAPK Signaling Cascades
8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
02:15M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
02:39Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
01:22PI3K/mTOR/AKT Signaling Pathway
6.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.0K
01:16Calmodulin-dependent Signaling
6.8K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.8K